Meeting
2018 ASCO Quality Care Symposium
Enhanced compliance with appropriate antiemetic prescribing guidelines by utilizing a medically integrated pharmacy antiemetic therapeutic interchange protocol.
Authors
Lalan S. Wilfong
Texas Oncology, Dallas, TX
Lalan S. Wilfong, Carla Portnoy, J. Russell Hoverman, Kathryn Wallace, Jim R. Schwartz, Neal Dave, Sabrina Q. Mikan, Debra A. Patt
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Big Data Studies; Projects Relating to Equity, Value, and Policy
Track
Projects Relating to Equity, Value and Policy,Big Data Studies
Sub Track
Guideline Concordant Care Initiatives
Citation
J Clin Oncol 36, 2018 (suppl 30; abstr 55)
DOI
10.1200/JCO.2018.36.30_suppl.55
Abstract #
55
Poster Bd #
F8
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Guideline-concordant use of olanzapine as part of a 4-drug antiemetic regimen for high emetic risk chemotherapy across the state of Michigan.
First Author: Ashley Bowen
Poster
2022 ASCO Quality Care Symposium
Patterns of olanzapine prescribing for those receiving highly emetogenic chemotherapy.
First Author: Daniel S Childs
Poster
2023 ASCO Quality Care Symposium
Outcomes of clinical pharmacist integration in a community oncology practice.
First Author: Katie Sias
Poster
2020 ASCO Quality Care Symposium
Use of antiemetic prophylaxis and oral breakthrough medication for highly emetogenic chemotherapy (HEC) in a large community oncology network.
First Author: Garrett Young